Causes and outcome of hospitalization among HIV-infected adults receiving antiretroviral therapy in Mulago hospital, Uganda
Background: Cohorts describing cause specific mortality in HIV-infected patients initiating antiretroviral therapy (ART) operate on an outpatient basis. Hospitalized patients represent the spectrum and burden of severe morbidity and mortality in patients on ART. Objective: To determine the causes an...
Saved in:
Published in: | African health sciences Vol. 13; no. 4; pp. 977 - 985 |
---|---|
Main Authors: | , , |
Format: | Journal Article |
Language: | English |
Published: |
Uganda
Makerere University Medical School
01-12-2013
Makerere Medical School |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background: Cohorts describing cause specific mortality in HIV-infected
patients initiating antiretroviral therapy (ART) operate on an
outpatient basis. Hospitalized patients represent the spectrum and
burden of severe morbidity and mortality in patients on ART. Objective:
To determine the causes and outcomes of hospitalization among adults
receiving ART. Methods: A prospective cohort study. We enrolled 201
participants (50% female) with median (IQR) age and CD4 count of 34
(28-40) years and 91(29-211) cells/uL respectively. Results: The most
frequent causes of hospitalization were tuberculosis (TB) (37, 18%),
cryptococcal meningitis (22, 11%),zidovudine (AZT)- associated anemia
(19, 10%), sepsis (10, 5%) and Kaposi's sarcoma (10, 5%). Forty
two patients (21%) died: 10 (24%) had TB, 8 (19%) had cryptococcal
meningitis and 5 (12%) had sepsis, 9 (21%) had undiagnosed neurological
syndromes while 10 (24%) had other illnesses. Predictors of death
included low Karnofsky performance score of < 40 (OR, 21.1; CI 1.43-
31.6) and age >34 years (OR, 7.65; CI 1.09- 53.8). Conclusions:
Opportunistic infections, malignancy and AZT-associated anemia
contributed to most hospitalizations and mortality. It is important to
intensify prevention, screening, and treatment for these opportunistic
diseases and early ART initiation in HIV-infected patients.
Tenofovir-based regimens, unless contraindicated should be scaled up to
replace AZT based regimens as first line ART drugs. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1680-6905 1729-0503 1680-6905 |
DOI: | 10.4314/ahs.v13i4.17 |